Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 11.12
(-0.54%)
CNY 11.12
(-0.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -6.38 Million CNY | 95.19% |
| 2022 | -132.68 Million CNY | -397.42% |
| 2021 | -26.67 Million CNY | -112.78% |
| 2020 | 208.73 Million CNY | 322.89% |
| 2019 | 49.35 Million CNY | 87.5% |
| 2018 | 26.32 Million CNY | -11.57% |
| 2017 | 29.77 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 9.43 Million CNY | 109.11% |
| 2024 Q1 | -16.3 Million CNY | -155.37% |
| 2024 Q2 | -103.58 Million CNY | -535.21% |
| 2023 Q3 | -359.51 Million CNY | -50.57% |
| 2023 FY | -6.38 Million CNY | 95.19% |
| 2023 Q4 | -6.38 Million CNY | 98.22% |
| 2023 Q2 | -238.76 Million CNY | -10.17% |
| 2023 Q1 | -216.71 Million CNY | -63.33% |
| 2022 Q3 | -66.35 Million CNY | 38.85% |
| 2022 Q2 | -108.51 Million CNY | -12.76% |
| 2022 Q1 | -96.23 Million CNY | -260.77% |
| 2022 FY | -132.68 Million CNY | -397.42% |
| 2022 Q4 | -132.68 Million CNY | -99.96% |
| 2021 FY | -26.67 Million CNY | -112.78% |
| 2021 Q1 | 264.5 Million CNY | 26.72% |
| 2021 Q4 | -26.67 Million CNY | 71.94% |
| 2021 Q3 | -95.06 Million CNY | -130.62% |
| 2021 Q2 | 310.48 Million CNY | 17.38% |
| 2020 FY | 208.73 Million CNY | 322.89% |
| 2020 Q1 | 16.68 Million CNY | 0.0% |
| 2020 Q4 | 208.73 Million CNY | 0.0% |
| 2020 Q2 | 224.16 Million CNY | 1243.74% |
| 2019 FY | 49.35 Million CNY | 87.5% |
| 2018 FY | 26.32 Million CNY | -11.57% |
| 2017 FY | 29.77 Million CNY | 0.0% |